We then examined the effects of RCC1 knockdown on 5-FU- or doxorubicin (Doxo)-induced cell cycle arrest and apoptosis in both parental and drug-resistant CRC cell lines. The gene discussed is RCC1; the disease is colorectal carcinoma.